Viewing Study NCT05333458


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-06 @ 8:05 AM
Study NCT ID: NCT05333458
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module